MedicalEye surgery robot
JASPER (formerly Oryom)
JASPER is a robot for cataract surgery (replacing the clouded lens of the eye), still being tested. A surgeon controls it from a distance at every step. It used to be called Oryom. ForSight Robotics press release, 6 Aug 2026
- Evidence
- Company-reported only
- Human help
- None reported
- Last milestone
- 6 Aug 2026
01Can I get it?
Only through a trial
- Where it works today
- Only in a clinical study so far; not FDA-cleared and not on sale in the US. ForSight Robotics press release, 6 Aug 2026
- Published price
- No published price in our sources.
- Human help
- A surgeon controls the robot throughout the operation; it does not operate on its own. ForSight Robotics press release, 6 Aug 2026
02Track record
What has actually happened
Every milestone is dated and links to the page it comes from. Lines marked company-reported rest on the maker's own word.
03Promised vs delivered
What the maker said, and when
Dated targets the maker set in public, against what has happened since.
- Said24 June 2025
First human trials in 2025
When it raised $125 million, ForSight said it would start its first trials in people that year. MassDevice, 24 June 2025
MissedThe first operation on a person was announced in April 2026.
- Said7 April 2026
Clinical validation and regulatory filings (no date given)
After the first operation, ForSight said its next steps are more studies and filings with regulators. It gave no date. MassDevice, 7 Apr 2026
Still pendingAs of August 2026 the robot was not FDA-cleared.
04Safety and incidents
What has gone wrong
No crashes, recalls or regulator reports in our sources. That is not proof none happened; we add them when a regulator or trusted outlet reports one.
In clinical trials
1 registered trial
1 looking for volunteers. From ClinicalTrials.gov, read every day.
How we placed it
The rule, not an opinion
Stages are worked out by published rules from the dated milestones above. We never rate robots, and no maker can pay to change a stage.
- 5
Regulator-cleared or mass market
A regulator has cleared it where approval applies: FDA clearance or approval for a medical robot, a permit to run with no one aboard for a self-driving vehicle, or an FAA approval for routine drone flights. Or: Widely sold: sales in the hundreds of thousands, or a product category you can buy in ordinary shops.
- 4
Paying customers
Delivered to customers who pay for it, beyond a trial, or a paid service the public can use.
- 3
PilotThis robot
Working with a named customer in a real setting, as a trial.
Placed by: ForSight said surgeons did the first cataract operation on a human patient with the robot, now renamed JASPER. The study's lead doctor is at the Asian Eye Institute in Manila, Philippines (7 April 2026).
- 2
Pre-orders
Orders, reservations or deposits taken, with nothing delivered yet.
- 1
Demo only
Shown in videos, staged events or a factory, with no units working for customers.
What we couldn't confirm. All patient numbers come from the company. The exact date of the first human operation and the number of trial sites were not stated in the sources opened.
Sources
- 01ForSight Robotics press release, 6 Aug 2026
- 02MassDevice, 7 Apr 2026
- 03MassDevice, 24 June 2025
- 04MassDevice, 9 Mar 2021
Cite this page
Robotics Verdict. “JASPER (formerly Oryom) (ForSight Robotics): how far has it got?” roboticsverdict.com/robots/forsight. Checked 19 October 2026.
More in Surgical and medical
- AquaBeam and HYDROS (Aquablation)PROCEPT BioRobotics · Cleared or mass market
- ARTASVenus Concept (formerly Restoration Robotics) · Cleared or mass market
- CORI Surgical SystemSmith+Nephew · Cleared or mass market
- CyberKnifeAccuray · Cleared or mass market
- da Vinci 5Intuitive · Cleared or mass market
- da Vinci SPIntuitive · Cleared or mass market
